EDN1 and systemic sclerosis: Reduction of nitric oxide (NO), an efficient vasodilator, and increasing ET-1 expression appear to be responsible for vascular abnormalities like vasospasm, which is responsible for Raynaud’s phenomenon, a common symptom in SSc patients [54, 86].